No, he doesn't know what he is doing. He destroyed Regeneus and will do the same again.
The joke about ASX-listed biotechs is that they have CEOs on 7 figures + stock options + bonus whereas these companies have little to no revenue and a capitalisation below $10m.
We live in a crazy world where some loud, extroverted people fake expertise by being pretending and by networking board members but deliver zero value to companies and their shareholders. But hey, they great at selling dreams, sorry "Board room narratives".
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.844M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 15838 | 2 |
View Market Depth
| Last trade - 16.21pm 25/07/2025 (20 minute delay) ? |
| CMB (ASX) Chart |
Day chart unavailable